Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prostate carcinoma
|
1168 | 0.695 | 0.320 | 12 | 12718165 | missense variant | T/A;C;G | snv | 1.6E-04; 1.6E-05; 0.26 | 0.730 | 0.750 | 4 | 2004 | 2019 | |||||
Carcinogenesis
|
355 | 0.695 | 0.320 | 12 | 12718165 | missense variant | T/A;C;G | snv | 1.6E-04; 1.6E-05; 0.26 | 0.030 | 1.000 | 3 | 2014 | 2015 | |||||
Malignant neoplasm of prostate
|
1082 | 0.695 | 0.320 | 12 | 12718165 | missense variant | T/A;C;G | snv | 1.6E-04; 1.6E-05; 0.26 | 0.030 | 0.667 | 3 | 2004 | 2019 | |||||
Breast Carcinoma
|
2793 | 0.695 | 0.320 | 12 | 12718165 | missense variant | T/A;C;G | snv | 1.6E-04; 1.6E-05; 0.26 | 0.020 | 0.500 | 2 | 2006 | 2014 | |||||
Carcinoma, Ovarian Epithelial
|
327 | 0.695 | 0.320 | 12 | 12718165 | missense variant | T/A;C;G | snv | 1.6E-04; 1.6E-05; 0.26 | 0.020 | 1.000 | 2 | 2013 | 2015 | |||||
Malignant neoplasm of breast
|
3417 | 0.695 | 0.320 | 12 | 12718165 | missense variant | T/A;C;G | snv | 1.6E-04; 1.6E-05; 0.26 | 0.020 | 0.500 | 2 | 2006 | 2014 | |||||
Malignant neoplasm of ovary
|
315 | 0.695 | 0.320 | 12 | 12718165 | missense variant | T/A;C;G | snv | 1.6E-04; 1.6E-05; 0.26 | 0.020 | 1.000 | 2 | 2013 | 2015 | |||||
Malignant Neoplasms
|
1641 | 0.695 | 0.320 | 12 | 12718165 | missense variant | T/A;C;G | snv | 1.6E-04; 1.6E-05; 0.26 | 0.020 | 1.000 | 2 | 2012 | 2015 | |||||
Neoplasms
|
1644 | 0.695 | 0.320 | 12 | 12718165 | missense variant | T/A;C;G | snv | 1.6E-04; 1.6E-05; 0.26 | 0.020 | 1.000 | 2 | 2005 | 2014 | |||||
ovarian neoplasm
|
757 | 0.695 | 0.320 | 12 | 12718165 | missense variant | T/A;C;G | snv | 1.6E-04; 1.6E-05; 0.26 | 0.020 | 1.000 | 2 | 2013 | 2015 | |||||
Primary malignant neoplasm
|
1374 | 0.695 | 0.320 | 12 | 12718165 | missense variant | T/A;C;G | snv | 1.6E-04; 1.6E-05; 0.26 | 0.020 | 1.000 | 2 | 2012 | 2015 | |||||
ACTH-Secreting Pituitary Adenoma
|
5 | 0.695 | 0.320 | 12 | 12718165 | missense variant | T/A;C;G | snv | 1.6E-04; 1.6E-05; 0.26 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Liver carcinoma
|
942 | 0.695 | 0.320 | 12 | 12718165 | missense variant | T/A;C;G | snv | 1.6E-04; 1.6E-05; 0.26 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Malignant neoplasm of pancreas
|
277 | 0.695 | 0.320 | 12 | 12718165 | missense variant | T/A;C;G | snv | 1.6E-04; 1.6E-05; 0.26 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Multiple Endocrine Neoplasia Type 1
|
156 | 0.695 | 0.320 | 12 | 12718165 | missense variant | T/A;C;G | snv | 1.6E-04; 1.6E-05; 0.26 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Node-negative breast cancer
|
2 | 0.695 | 0.320 | 12 | 12718165 | missense variant | T/A;C;G | snv | 1.6E-04; 1.6E-05; 0.26 | 0.010 | 1.000 | 1 | 2005 | 2005 | |||||
Pancreatic carcinoma
|
322 | 0.695 | 0.320 | 12 | 12718165 | missense variant | T/A;C;G | snv | 1.6E-04; 1.6E-05; 0.26 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Pancreatic Neoplasm
|
20 | 0.695 | 0.320 | 12 | 12718165 | missense variant | T/A;C;G | snv | 1.6E-04; 1.6E-05; 0.26 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Papillary thyroid carcinoma
|
204 | 0.695 | 0.320 | 12 | 12718165 | missense variant | T/A;C;G | snv | 1.6E-04; 1.6E-05; 0.26 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Parathyroid Adenoma
|
12 | 0.695 | 0.320 | 12 | 12718165 | missense variant | T/A;C;G | snv | 1.6E-04; 1.6E-05; 0.26 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
THYROID CARCINOMA, SPORADIC MEDULLARY
|
11 | 0.695 | 0.320 | 12 | 12718165 | missense variant | T/A;C;G | snv | 1.6E-04; 1.6E-05; 0.26 | 0.010 | 1.000 | 1 | 2011 | 2011 |